Coming Soon
Understanding Moderate Cognitive Impairment (MCI) diagnosis, clinical documentation, and medical coding? Find information on MCI diagnostic criteria, ICD-10 codes for MCI, cognitive assessment tools, and healthcare provider resources for managing and documenting MCI. Learn about MCI progression, cognitive decline, and treatment options. This resource offers guidance for accurate clinical documentation and appropriate medical coding for Moderate Cognitive Impairment.
Also known as
Mild cognitive impairment
Moderate cognitive decline not dementia.
Mild neurocognitive disorder
Cognitive decline affecting daily activities.
Cognitive functions, unspecified
Unspecified problems with cognitive abilities.
When to use each related code
| Description |
|---|
| Moderate cognitive decline |
| Mild cognitive impairment |
| Mild neurocognitive disorder |
Using unspecified MCI codes (e.g., G31.84) when a more specific code is documented, impacting data accuracy and reimbursement.
Incorrectly coding MCI with overlapping conditions like dementia or depression, leading to inflated case severity and inaccurate reporting.
Coding MCI without adequate clinical documentation of cognitive decline, impacting audit validity and potentially triggering denials.
Patient presents with concerns of gradual cognitive decline, impacting daily functioning, consistent with a diagnosis of Moderate Cognitive Impairment (MCI). The patient reports subjective cognitive complaints corroborated by an informant, primarily in the domains of memory, executive function, and language. Formal neuropsychological testing reveals performance below age and education-adjusted norms, but does not meet criteria for dementia. Activities of daily living (ADLs) are preserved, although instrumental activities of daily living (IADLs) such as financial management and medication management show early signs of impairment. The patient denies significant psychiatric history and current mood symptoms. Neurological examination is unremarkable. Differential diagnoses considered include Alzheimer's disease, vascular dementia, and depression. Laboratory workup including complete blood count (CBC), comprehensive metabolic panel (CMP), thyroid stimulating hormone (TSH), vitamin B12, and syphilis serology is ordered to rule out reversible causes of cognitive impairment. Neuroimaging, specifically magnetic resonance imaging (MRI) of the brain, is recommended to assess for structural abnormalities. A Montreal Cognitive Assessment (MoCA) score of 19 supports the clinical impression of MCI. ICD-10 code G31.84 (Mild cognitive impairment, so stated) is applied, pending further diagnostic evaluation. The patient and family are educated about MCI, its prognosis, and potential progression to dementia. Treatment plan includes cognitive rehabilitation strategies, recommendations for lifestyle modifications including regular exercise and a Mediterranean diet, and close monitoring of cognitive function with follow-up appointments scheduled every six months. Referral to a neurologist specializing in cognitive disorders is placed. Patient and family express understanding of the diagnosis and plan.